Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 14,573 shares, a growth of 211.9% from the July 30th total of 4,673 shares. Based on an average daily trading volume, of 4,750 shares, the short-interest ratio is currently 3.1 days. Approximately 0.0% of the company’s shares are sold short.
Cardiac Biotech Solutions Price Performance
Shares of CBSC stock opened at $0.04 on Thursday. The stock has a 50-day moving average of $0.03 and a 200-day moving average of $0.04. Cardiac Biotech Solutions has a 1-year low of $0.02 and a 1-year high of $0.06.
About Cardiac Biotech Solutions
CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.
Featured Stories
- Five stocks we like better than Cardiac Biotech Solutions
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
